Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 10/20 | 0.78 |
| ▸ | PGR | P06401 | 2/20 | 0.78 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 2/20 | 0.78 |
| ▸ | AR | P10275 | 1/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.78 |
| ▸ | NR3C1 | P04150 | 7/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.75 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.75 |
| ▸ | SHBG | P04278 | 1/20 | 0.75 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.70 |
| ▸ | TSHR | P16473 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL332584 | 0.93 | HIF1A (0.78) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL11144452 | 0.93 | HIF1A (0.78) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL12235695 | 0.93 | HIF1A (0.78) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL11281433 | 0.93 | HIF1A (0.78) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL14867487 | 0.92 | HIF1A (0.84) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL4618329 | 0.90 | HIF1A (0.84) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL13368121 | 0.90 | HIF1A (0.84) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL9073513 | 0.88 | HIF1A (0.71) | HIF1APGRSERPINA6LMNAAR | |
| SCHEMBL12396664 | 0.88 | HIF1A (0.71) | HIF1APGRSERPINA6LMNAAR | |
| Hydrocortisone SCHEMBL2803365 | 0.88 | HIF1A (0.93) | HIF1APGRSERPINA6LMNAAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119202880-B | Typhoon remote storm rapid identification method based on AI meteorological model, storage medium and computer program product | 中国气象科学研究院 | 2025-06-13 | — | — | CN | claimed |
| CN-119202880-A | Typhoon remote storm rapid identification method based on AI meteorological model, storage medium and computer program product | 中国气象科学研究院 | 2024-12-27 | — | — | CN | claimed |
| CN-114388841-B | Thermal component for solid oxide fuel cell system and preparation method thereof | 广东省科学院新材料研究所 | 2024-11-01 | — | — | CN | claimed |
| WO-2024201291-A1 | A PROCESS FOR MANUFACTURING INLET PIPES FOR EXHAUST SYSTEMS | TENNECO CLEAN AIR INDIA PVT. LTD. (IN) | 2024-10-03 | — | — | WO | claimed |
| CN-117648763-B | CST-EGO multi-parameter optimization design method of synergistic jet wing profile | 中国科学院工程热物理研究所 | 2024-03-29 | — | — | CN | claimed |
| CN-117648763-A | CST-EGO multi-parameter optimization design method of synergistic jet wing profile | 中国科学院工程热物理研究所 | 2024-03-05 | — | — | CN | claimed |
| US-20230149519-A1 | VARIANT SULFATASE ENZYMES WITH ENHANCED PROPERTIES | INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. | 2023-05-18 | — | — | US | claimed |
| US-11555818-B2 | Method for the diagnosis and prognosis of cancer | The USA, as represted by the Secretary, Dept. of and Human Services, National Institutes of Health (US) | 2023-01-17 | — | — | US | claimed |
| CN-114388841-A | Hot component for solid oxide fuel cell system and preparation method thereof | 广东省科学院新材料研究所 | 2022-04-22 | — | — | CN | claimed |
| EP-3019871-B1 | METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER | US HEALTH (US) | 2019-10-16 | — | — | EP | claimed |
| US-10393745-B2 | Method for the diagnosis and prognosis of cancer | The USA, as represented by the Secretary, Department of Heath and Human Services (US) | 2019-08-27 | — | — | US | claimed |
| US-20160169899-A1 | METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER | THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES | 2016-06-16 | — | — | US | claimed |
| EP-3019871-A2 | METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2016-05-18 | — | — | EP | claimed |
| WO-2015006657-A2 | METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF CANCER | THE UNITETD STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2015-01-15 | — | — | WO | claimed |
| US-4082613-A | PSEUDOSACCHAROMYCETE | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1978-04-04 | — | — | US | claimed |
| US-20260139001-A1 | EVOLUTION OF FLUOROGENIC SENSORS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2026-05-21 | — | — | US | disclosed |
| US-12620605-B2 | Power connection for electrochemical cell stack | CERES INTELLECTUAL PROPERTY COMPANY LIMITED (GB) | 2026-05-05 | — | — | US | disclosed |
| US-20100196436-A1 | IMPLANTS CONTAINING DISULFIRAM AND AN ANTI-INFLAMMATORY AGENT | GOOBERMAN LANCE L | 2010-08-05 | — | — | US | disclosed |
| US-6203813-B1 | OPIATE ANTAGONIST, STEROIDAL ANTIINFLAMMATORY AGENT AND CARRIER; SUSTAINED RELEASE; DRUG ABUSE TREATMENT | GOOBERMAN, LANCE L. | 2001-03-20 | — | — | US | disclosed |
| US-4082613-A | PSEUDOSACCHAROMYCETE | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1978-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139001-A1 | EVOLUTION OF FLUOROGENIC SENSORS | EIF2A, SARS1, EIF2B1 | HIF1A 3853/4885PGR 2912/4885SERPINA6 2661/4885 |
| US-12620605-B2 | Power connection for electrochemical cell stack | GJA1, EPCAM, PIEZO1 | HIF1A 4123/4885PGR 2460/4885SERPINA6 653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.